Skip to content
Experts told a House subcommittee Wednesday that China’s government coordinates a strategy to steal U.S. intellectual property – and the waiver of COVID IP would […]
Congress shines a light on China’s strategy to steal U.S. IP Read More »
On March 6, 2023, the United States Trade Representative (USTR) made a request for technical consultations concerning Mexico’s biotech corn ban under the U.S.-Mexico-Canada
U.S. takes step toward legal resolution of Mexico’s biotech corn ban Read More »
With the emergence of COVID-19 and the lack of timely response, the international community instantly realized that a foolproof plan for future pandemics is
Pharma recommends five essential priorities for future pandemic preparedness Read More »
Vulnerability to the impacts of climate change has been studied extensively in recent years but two new studies highlight specific impacts of changing weather
Human health seriously impacted by changing weather and air pollution Read More »
Mexico yesterday announced a modified decree regarding U.S. imports of biotech corn for animal feed. However, the change does not appear to stop the ban on
UPDATED: Mexico issues modified decree on biotech corn – but it’s not enough Read More »
Last week, Reuters reported that Doug McKalip, the new U.S. Trade Representative’s (USTR) Chief Agricultural Trade Negotiator, told Mexico that it has “until Feb.
Mexico needs to ‘explain the science’ behind its corn ban Read More »
“I think we’re in a very exciting time in healthcare and biotech,” said Steven Ladd, Director of Business Development and Acquisitions at AbbVie. “It’s
China-U.S. biotech ventures are where collaboration meets competition Read More »
The World Health Organization (WHO) suggests additional waivers of intellectual property rights during the next pandemic in the initial draft of its global pandemic
Draft WHO pandemic treaty suggests future IP waivers Read More »
The intellectual property protections that enabled the record-setting development of COVID-19 vaccines and treatments require rigorous federal protection, says the Biotechnology Innovation Organization (BIO)
BIO recommends 11 countries for USTR’s Priority Watch List Read More »
In light of the drastic rebate hike prompted by inflation and COVID-driven increases in demand, the U.K. is no longer a viable market for
European lessons on drug price controls teach the U.S. how ‘not to do it’ Read More »
